Spirax-Sarco reported Q4 2024 revenue of £1.67 billion, a slight decrease from the previous year. Adjusted operating profit stood at £333.9 million, with an adjusted operating margin of 20.1%. Organic growth remained strong across all business segments, particularly in ETS and WMFTS. The company also improved cash conversion, reduced leverage, and took strategic restructuring actions to simplify operations and enhance efficiency.
Revenue slightly declined by 1% year-over-year to £1.67 billion.
Adjusted operating profit stood at £333.9 million, with a 20.1% margin.
ETS and WMFTS segments drove organic growth with double-digit improvements.
Operational efficiencies and restructuring efforts resulted in cost savings.
Spirax-Sarco expects stable organic revenue growth, continued margin improvements, and restructuring benefits in 2025.